CollPlant Biotechnologies CLGN
NASDAQ CLGN
$0.31 +0.01 (+4.06%)
As of: Aug 21, 2026 · 3:59 PM EDT

CollPlant Biotechnologies (CLGN) Goodwill & Intangibles (2017 - 2025)

CollPlant Biotechnologies' (CLGN) quarterly Goodwill & Intangibles came in at $73000.0 in Q4 2025, down 99.94% YoY from $131.0 million in Q4 2024, and down 28.43% on a QoQ basis from $102000.0 in Q2 2025.

CollPlant Biotechnologies (CLGN) Goodwill & Intangibles (2017 - 2025) Analysis & Trends

CollPlant Biotechnologies (CLGN) has 9 years of Goodwill & Intangibles data on file, last reported at $73000.0 in Q4 2025.

  • Quarterly Goodwill & Intangibles fell 99.94% year-over-year to $73000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $73000.0 (down 99.94% YoY) and the FY2025 annual result came in at $73000.0, down 99.94% from the prior year.
  • Goodwill & Intangibles declined to $73000.0 in Q4 2025, from $102000.0 in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $243.0 billion in Q4 2021 to a low of $73000.0 in Q4 2025.
  • A 5-year average of $13.6 billion and a median of $236500.0 in 2022 frame the typical range for Goodwill & Intangibles.
  • Annual changes were most pronounced in 2021 — Goodwill & Intangibles surged 296341363.41% — and 2025, when it slumped 99.94%.
  • Tracing CLGN's Goodwill & Intangibles over 5 years: stood at $243.0 billion in 2021, then plunged by 99.9% to $245.0 million in 2022, then tumbled by 99.92% to $188000.0 in 2023, then surged by 69580.85% to $131.0 million in 2024, then tumbled by 99.94% to $73000.0 in 2025.
  • The last three Goodwill & Intangibles figures came in at $73000.0 (Q4 2025), $102000.0 (Q2 2025), and $131.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 CollPlant Biotechnologies 4.26 Mn 4.26 Mn -243,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 73,000.00
Jun 30, 2025 102,000.00
Dec 31, 2024 131.00 Mn
Sep 30, 2024 145.00 Mn
Jun 30, 2024 159,000.00
Mar 31, 2024 173.00 Mn
Dec 31, 2023 188,000.00
Sep 30, 2023 202.00 Mn
Jun 30, 2023 216,000.00
Mar 31, 2023 231,000.00
Dec 31, 2022 245.00 Mn
Sep 30, 2022 238,000.00
Jun 30, 2022 235,000.00
Mar 31, 2022 239,000.00
Dec 31, 2021 243.00 Bn
Sep 30, 2021 194,000.00
Jun 30, 2021 164,000.00
Mar 31, 2021 138.00 Mn
Dec 31, 2020 82,000.00
Sep 30, 2020 46,000.00